We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Evogene Ltd | NASDAQ:EVGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.07 | 2.49% | 2.88 | 2.76 | 3.07 | 2.955 | 2.80 | 2.83 | 10,376 | 01:00:00 |
Exhibit
|
|
|
Number
|
|
Exhibit Description
|
Date: August 12, 2024 |
EVOGENE LTD.
(Registrant) By: /s/ Yaron Eldad —————————————— Yaron Eldad Chief Financial Officer |
1.
|
Biomica Ltd. (www.biomicamed.com)
developing and advancing novel microbiome-based therapeutics to treat human disorders powered by MicroBoost AI;
|
2.
|
Lavie Bio Ltd. (www.lavie-bio.com) - developing and commercially advancing, microbiome based ag-biologicals powered by MicroBoost AI;
|
3.
|
AgPlenus Ltd. (www.agplenus.com)
-developing next generation ag chemicals for effective and sustainable crop protection powered by ChemPass AI;
|
4.
|
Casterra Ag Ltd. (www.casterra.co)–
developing and marketing superior castor seed varieties producing high yield and high-grade oil content, on an industrial scale for the biofuel and other industries powered by GeneRator AI.
|
Evogene Investor Contact:
|
Rachel Pomerantz Gerber
Head of Investor Relations at Evogene
rachel.pomerantz@evogene.com
Tel: +972-8-9311901
|
1 Year Evogene Chart |
1 Month Evogene Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions